Notice2022-24060
National Institute of Allergy and Infectious Diseases; Amended Notice of Meeting
Primary source
Metadata and text below are from the Federal Register, a public-domain U.S. government work. Always verify the official published version before relying on it for any legal matter.
Published
November 4, 2022
Issuing agencies
Health and Human Services DepartmentNational Institutes of Health
Full Text
<html>
<head>
<title>Federal Register, Volume 87 Issue 213 (Friday, November 4, 2022)</title>
</head>
<body><pre>
[Federal Register Volume 87, Number 213 (Friday, November 4, 2022)]
[Notices]
[Page 66718]
From the Federal Register Online via the Government Publishing Office [<a href="http://www.gpo.gov">www.gpo.gov</a>]
[FR Doc No: 2022-24060]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Amended
Notice of Meeting
Notice is hereby given of a change in the meeting of the National
Institute of Allergy and Infectious Diseases Special Emphasis Panel
NIAID Investigator Initiated Program Project Applications (P01 Clinical
Trial Not Allowed) which was published in the Federal Register on
October 28, 2022, FR Doc 2022-23540, 87 FR 65215.
Amendment to change meeting date and time from November 14, 2022,
at 2:00 p.m. to 5:00 p.m. to November 15, 2022, at 1:00 p.m. to 4:00
p.m. The meeting is closed to the public.
Dated: November 1, 2022.
Tyeshia M. Roberson-Curtis,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-24060 Filed 11-3-22; 8:45 am]
BILLING CODE 4140-01-P
</pre></body>
</html>Indexed from Federal Register on November 4, 2022.
This is legal information, not legal advice. Laws vary by jurisdiction and change frequently. Always verify current law with official sources and consult a licensed attorney in your jurisdiction for advice on your specific situation.